US-based ventilation monitoring firm Respiratory Motion and Chinese firm Corestone Biosciences have signed an agreement to form a joint venture (JV) company in China.
The JV is set to provide new respiratory volume monitors that will be designed based on Respiratory Motion’s ExSpiron platform.
Intended to cater to the Chinese, as well as other international markets, the JV will additionally offer new critical care solutions for hospital and home care segments.
Corestone Biosciences chairman Weiping Yang said: “The establishment of this joint venture with CorestoneBio comes at a time of growing demand for respiratory solutions in China and globally.
“Respiratory Motion is an ideal partner in our efforts to meet the demand of physicians in China who have been waiting for a product that can reliably identify and continuously monitor respiratory compromise.”
Apart from the ExSpiron Basic Monitoring Software (ExBMS) for non-invasive respiratory measurement, Respiratory Motion will contribute its expertise in the development of high-tech monitoring platforms.
ExBMS is developed for accurate and reliable measurement of patient respiration, eliminating the need for calibration.
Respiratory Motion expects that the collaboration will result in enhanced manufacturing capabilities, product offerings and global expansion.
JV company CEO Francis Cao said: “Combining the resources of Corestone Biosciences and Respiratory motion will enable us to deliver an accelerated product launch and become a leading provider of novel respiratory and other healthcare solutions in China and worldwide.”